Seizures Flashcards
What is a seizure?
a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain
What is epilepsy?
disorder of the brain characterized by an enduring predisposition to generate epileptic seizures
How does the epilepsy diagnosis differ now compared to 2015?
2015: diagnosis required pt to have a min of 2 seizures 24h apart
now: diagnosis expanded to include pts with only 1 unprovoked seizure but at significant risk of sz recurrence
-EEG with epileptiform abnormalities, brain injury, structural brain abnormalities, nocturnal seizures
What is an unprovoked seizure?
one which occurs in the absence of an acute brain injury (e.g. stroke, head trauma, infection, metabolic/toxic insult)
What is the 2nd most common neurological disorder in the world?
seizures/epilepsy
What is the etiology of seizures?
largely unknown, variable causes
-metabolic
-immune
-infection
-genetics
-structural lesions in the brain (acquired or genetic)
anything that disturbs the normal functioning of the cerebral cortex can cause seizures, and if this abnormality is enduring, it can result in epilepsy
Describe the pathophysiology of seizures.
synchronous hyperexcitability of szs may be due to:
-increased excitatory synaptic neurotransmission
-decreased inhibitory synaptic neurotransmission
-alteration of voltage-gated ion channels
-alteration of intra or extracellular ion []’s
-hypersynchrony (recruitment of neighboring neurons into abnormal firing mode)
many ASMs target +1 of these possible causes
What are the impacts of seizures on patients lives?
stigma
fear of seizures
injuries
hospitalizations
mortality
MDD and anxiety
lost productivity
What is a critical aspect with regards to selecting the most appropriate ASM?
accurate seizure classification
not all ASMs treat all seizure types and some drugs can lead to seizure worsening when used for the incorrect seizure type
How are seizures differentiated according to onset?
focal:
-originate within networks limited to one hemisphere
generalized:
-originate at some point within, and rapidly engaging, bilaterally distributed networks
unknown:
-reflects the difficulty to classify unwitnessed seizures and those that occur while the patient is asleep
What can focal seizures progress to?
bilateral tonic clonic
What is status epilepticus?
medical emergency
any recurrent or continuous seizure activity lasting > 30 mins in which the patient does not regain baseline mental status
-or a cluster of seizures that does not return to baseline for > 30 mins
any seizure that does not stop within 5 min should be treated as impending status epilepticus
What is the main class of drugs used to treat status epilepticus?
BZDs: IV midazolam or lorazepam
What is the strategy that is often done to reduce the risk of progression to status epilepticus?
pts are often given “on demand” BZDs to use “prn” at the onset of seizures to decrease risk of progression to SE
-adults commonly: lorazepam 1-2 mg SL
-pediatrics: intranasal or buccal midazolam
-infants < 3 mo: rectal diazepam
What are post ictal symptoms?
an array of symptoms that can occur after a seizure
-confusion
-tired
-memory problems
-cognitive problems
-depression and anxiety
-headaches
Describe proper seizure first aid.
time it, longer than 5 mins = call an ambulance
-most seizures are over in 2-3 mins
explain what is going on, ask to be given space
cushion head and neck with something soft
do NOT restrain
do NOT put anything in their mouth
roll the person to their side to prevent choking
clear the area of dangers
speak gently, be kind during and after the seizure
What are some drugs that can lower the seizure threshold?
analgesics:
-opioids (especially meperidine, tramadol)
anticancer drugs
psychiatric drugs:
-SSRI, SNRI, TCA, bupropion, buspirone, lithium, APs (<clozapine), MAOI, atomoxetine
immunosuppressants:
-tacrolimus, cyclosporine, azathioprine, mycophenolate
stimulants:
-MPH, amphetamines
sympathomimetics and decongestants:
-PSE, PE, anorexiants
What are the many different aspects involved in the diagnosis of epilepsy?
based on combo of clinical history and physical/neuro exam
-not always possible to make a definitive diagnosis
clear, detailed, and accurate history is important
-reliable source of info is crucial (pt may forget!!)
diagnostics: EEG, CT +/- MRI, labwork
medication review
-identify high risk drugs
What is the role of EEG in the diagnosis of epilepsy?
both interictal and ictal recordings are informative
used to determine if focal vs generalized onset and estimating risk of recurrence
only a snapshot in time: may require multiple EEGs or admission
What is the role of brain imaging in the diagnosis of epilepsy?
used to identify structural brain abnormalities
NOT to observe seizure activity
Why does the diagnosis of epilepsy have to be approached with care?
misdiagnosis has life-altering implications
-driving restrictions
-social functioning
-AE from meds
-effects of long-term tx exposure
-employability
What are the goals of therapy for epilepsy?
complete seizure control (within min if SE, then ongoing)
-achievable in 60-70% of patients with epilepsy
decrease seizure frequency, severity, type (ongoing)
-in the 30-40% of patients that do not achieve control
improve QoL (ongoing)
minimize ADEs
reduce morbidity and mortality (ongoing)
Describe a general approach to treatment of seizures/epilepsy.
epilepsy diagnosis –>epilepsy classification–>care plan focused on:
-goals of therapy
-risk of seizure recurrence
-type of seizure/epilepsy
-prognosis
-available ASMs
-ADRs
What are the two main options for treatment of epilepsy?
pharmacotherapy or surgery
-epilepsy generally well controlled with drugs or surgery
-pharmacotherapy is pivotal to treatment
-surgery is an option for refractory cases (not all eligible)
What is the role of pharmacotherapy in acute seizures due to metabolic/toxic/infectious causes?
ASMs used in the short term but these are generally not continued once the patients medical problem has been resolved
When do we consider long-term treatment for seizures?
once diagnosis of epilepsy is made
-recall risk of recurrence is ~50% if pt has 1 unprovoked seizure and 60-90% if patient meets epilepsy diagnosis
-thus as 1/2 of pts who have 1 unprovoked seizure will not experience another seizure, long-term tx not started until pt meets epilepsy diagnosis
What are the general principles for initiating ASM therapy?
start with monotherapy
titrate slowly
-start at 1/4 to 1/3 of initial dose and increase q1-2wks
-minimizes risk of dose-dependent AEs
What is an example of an exception where we would not slowly titrate ASM therapy?
status epilepticus or high risk of harm from seizures –> loading doses
What are the potential approaches to take when there has been an inadequate response to initial ASM therapy?
inquire about medication adherence
if at a moderate dose with few AE –> titrate up to max dose
if continuing to experience seizures at maximum tolerable dose, consider:
-initiate a different 1st line ASM monotherapy (start new, taper old)
-initiate combination therapy by adding a 2nd ASM
What is the best approach to take when there has been an inadequate response to initial ASM therapy?
no single correct approach
When do we move towards polytherapy for inadequate responses to initial ASM therapy?
usually reserved for patients that have failed monotherapy with 2-3 drugs
-typically select an ASM with a different or complimentary MOA
What are the advantages of ASM monotherapy?
fewer idiosyncratic reactions
increases probability of adherence
more cost effective
What are the advantages of ASM polytherapy?
may have fewer side effects with lower doses of 2 concomitant ASMs
unclear if increases efficacy
True or false: all patients require lifelong ASM therapy
false
What is the risk vs benefit of discontinuing ASM therapy?
benefit:
-decreases polypharmacy, may decrease AE, improve cognition
risk:
-recurrent seizures and long-term seizure control may be lost
What are the factors favouring successful discontinuation of ASMs?
- seizure free (2yrs for children, 2-5yrs for adults)
- normal neurologic exam
- normalized EEG with treatment
- history of single type of focal seizure or generalized tonic-clonic seizures
How should ASMs be discontinued in non-emergency situations?
slow and gradual taper is best to prevent relapses and status epilepticus
-if on > 1 ASM, each one should be withdrawn separately
-no optimal rate identified, at least 6 weeks seems safe
What are the different non-pharm treatments for epilepsy?
ketogenic diet
surgery
vagus nerve stimulation
Describe the ketogenic diet as an approach to epilepsy.
high fat, low carb, adequate protein diet mimics state of starvation
-required strict compliance
-poorly tolerated by patients
may reduce seizure frequency
consider if have not responded to appropriate ASM therapy
Describe surgery as a treatment approach to epilepsy.
an option for some patients with refractory partial onset epilepsy resistant to multiple ASMs
the majority of patients achieve seizure-freedom
Describe vagus nerve stimulation as an approach to epilepsy.
surgical procedure to implant an electrical pulse generator in the chest and attach electrodes to the vagus nerve in the neck
pulse generator stimulates the vagus nerve on a regularly scheduled basis
may reduce seizure frequency
option in refractory focal onset or generalized seizures
What are some general non-pharm measures to take for epilepsy in all patients?
adequate sleep/nutrition
reduce alcohol intake
reduce stress/anxiety
avoid triggers
What are the many different MOAs of ASMs?
- modulation of voltage-gated ion channels (Na, K, Ca)
- increased inhibitory effect of GABA
- modulation of synaptic release
- inhibition of synaptic excitation
- glutamate receptor activity
- AMPA receptor activity
ASMs target 1 or more
What is a big contributor to treatment failure of ASMs?
ADEs
-due to non-adherence because of AEs
What can be said about the most common ADEs in relation to dose of ASMs?
most common ADEs are dose-dependent and reversible
Describe the acute dose-related toxicities of ASMs.
common (1-10%) or very common (>10%)
dose-dependent, predictable, reversible
CNS:
-sedation, dizziness, diplopia, blurred vision, ataxia, difficulty concentrating
GI:
-nausea, vomiting
Describe the idiosyncratic reactions of ASMs.
usually not concentration-dependent
uncommon (0.1-1%) to rare (<0.1%)
usually develop within first few weeks of treatment
unpredictable
often mild, but can be serious or life-threatening
Which hypersensitivity reactions are we concerned about with ASMs?
SJS and TENS
Which ASMs are the most likely to cause hypersensitivity reactions?
phenytoin
carbamazepine
lamotrigine
? lacosamide
What is a key thing to keep in mind when switching ASMs due to a hypersensitivity reaction caused by an ASM?
cross-sensitivity between agents is possible
-due to aromatic hydrocarbon ring
Which ASMs show cross-sensitivity amongst themselves?
carbamazepine
oxcarbazepine
esclicarbazepine
phenobarbital
primidone
phenytoin
lamotrigine
What is the risk of ASMs in women of childbearing years?
teratogenicity
What are general measures to take with ASMS in women of childbearing years?
discuss pregnancy plan prior to conception
ensure adequate folic acid supplementation
consider teratogenic effect of ASMs for all women of reproductive age
aim for seizure-freedom for 9-12 months prior to pregnancy
How can we try and prevent teratogenicity due to ASMs?
if possible avoid VA in women of childbearing years
-if used: IUD/Depo/implant
possible preferences: levetiracetam, lamotrigine
avoid polytherapy: withdraw least helpful ASM
use lowest effective dose
avoid stopping ASMs or switching meds during pregnancy
Which ASMS are strong CYP inducers?
phenytoin
carbamazepine
phenobarbital
Which ASMs are CYP inhibitors?
valproic acid
What is the significance regarding the use of ASMs with hormonal contraceptives?
many enzyme-inducing ASMS decrease efficacy of combined hormonal contraceptives
-ex: phenytoin, CBZ, primidone, phenobarbital
estrogen containing OCP reduces lamotrigine levels
Which contraceptives are preferred in combo with ASMs?
LNG IUD/copper IUD/implant
depo
COC with > 30 mcg EE taken continuously
What is the key message regarding therapeutic drug monitoring and ASMs?
treat the patient, not the number
-poor correlation between levels and clinical efficacy
When do we draw drug levels for ASMs?
- once the desired clinical response has been achieved, to establish “individual therapeutic range”
- to assist the clinician in determining the magnitude of a dose increase, particularly with ASMs showing dose-dependent PK
- when there are uncertainties in differential diagnosis of signs and symptoms suggestive of concentration-related ASM toxicity
- when seizures persist despite an apparently adequate dosage
- alteration in PK suspected (age/pregnancy/disease/DDI)
- assess changes in SS when formulation is changed
- change in clinical response
- poor compliance is suspected
What are examples of conventional ASMs?
phenytoin
benzodiazepines
carbamazepine
barbiturates
valproate
What are examples of newer ASMs?
levetiracetam
gabapentin
pregabalin
topiramate
lacosamide
lamotrigine